Skip to main content

Table 2 Comparison of therapeutic efficacy among experimental subgroups

From: RETRACTED ARTICLE: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients

Subgroups

Number of patients

Effective number of patients

Efficient rate (%)

Low expression of single gene

18

10

55.6bcd

Low expression of double gene

24

12

50acd

Low expression of triple gene

10

10

100abd

Non-low expression of triple gene

8

1

12.5abc

  1. P = 0.721 (a compared with b); P = 0.025 (a compared with c); P = 0.084 (a compared with d); P = 0.101 (b compared with c); P = 0.006 (b compared with d); P < 0.001 (c compared with d).